During the EAACI 2008 in Barcelona a satellite symposia, sponsored by
Jerini AG, was held. Lectures from key opinion leaders of major European
HAE centers gave a
broad overview about different aspects of hereditary angioedema (HAE) and the treatment option Icatibant.
The lectures were recorded on site and part of them are now available
as a
comprehensive web based medical education resource for physicians.
Hinweis: You must be registered as a healthcare professional to see the presentations.
Please log in, if requested.
HAE Range menu
EAACI 08: Satellite Symposium Icatibant HAE
EAACI 2008
- Dr. Teresa Caballero
Icatibant - a Novel Treatment Option for Hereditary Angioedema
Dr. Teresa Caballero, University Hospital La Paz, Madrid, Spain
- Prof. Marco Cicardi
Blocking the Bradykinin B2 Receptor with Icatibant: Results of the FAST-2 Trial
Prof Marco Cicardi, Department of Internal Medicine, University of Milan, Italy

- Dr. Avner Reshef
Clinical Experience with Icatibant: Dynamics of Clinical Response
Dr. Avner Reshef, Allergy & Immunology, Sheba Medical Center, Tel-Hashomer, Israel
| Frequently inquired |
Author: Jerini AG
Source: HAE-Network Status: 8/08 |



